---
category: news
title: "Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AIpowered Gene Therapy Platform"
excerpt: "Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced a $100 million Series A financing led by Andreessen Horowitz, with participation from a select syndicate of new investors including Casdin Capital,"
publishedDateTime: 2021-05-06T11:00:00Z
originalUrl: "https://www.financialbuzz.com/dyno-therapeutics-closes-100-million-series-a-financing-led-by-andreessen-horowitz-to-accelerate-aipowered-gene-therapy-platform/"
webUrl: "https://www.financialbuzz.com/dyno-therapeutics-closes-100-million-series-a-financing-led-by-andreessen-horowitz-to-accelerate-aipowered-gene-therapy-platform/"
type: article
quality: 5
heat: -1
published: false

provider:
  name: Financial Buzz
  domain: financialbuzz.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Dyno Therapeutics Closes $100M Series A Financing"
    excerpt: "Dyno Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company applying artificial intelligence (AI) to gene therapy, raised $100m in Series A financing"
    publishedDateTime: 2021-05-06T12:57:00Z
    webUrl: "https://www.finsmes.com/2021/05/dyno-therapeutics-closes-100m-series-a-financing.html"
    type: article
    provider:
      name: finsmes.com
      domain: finsmes.com
    quality: 24
    images:
      - url: "https://www.finsmes.com/wp-content/uploads/2021/05/dyno.jpg"
        width: 400
        height: 400
        isCached: true
  - title: "BRIEFâ€”Dyno Therapeutics raises $100 million for gene therapies"
    excerpt: "AI-driven gene therapy specialist Dyno Therapeutics has raised $100 million in a series A financing led by investment company Andreessen Horowitz. The firm said it would use the money to expand its CapsidMap platform,"
    publishedDateTime: 2021-05-06T15:51:00Z
    webUrl: "https://www.thepharmaletter.com/in-brief/brief-dyno-therapeutics-raises-100-million-for-gene-therapies"
    type: article
    provider:
      name: The Pharma Letter
      domain: thepharmaletter.com
    quality: 19

secured: "W6WzQBri8FZzZQ86l1SFlLdweOpJUg6HgZLrsfXTPdocQPeTlpD6fEAXnl9Y/JHY71JmACFqwyMqOPM/+K5o6sjEKJz6BoVVwODsh7WkqvLawXoJ5V64+88LhL9g448sjNOWtFignnd/hoAdm0QAKejJZLOPxNhRLqZEm1KMpR0z2d1Xh8VwYGWZrkkCmdB1OJISHKF+kgUY1GOt9F5aMK7M14bFjWp/Gyl/k9hyv3BWqFI+WVJi4LymRUI21ucQJUVtd5GjI1rG9P3mh7LcLfp1gGhI6+xpFHJ7wdMX8Y57QdxfVgp8tFNZDZPWgq4S45Ys7n6BB2aXsqXd13v6APdt5mZpUDP+kU+nqGQNsF4=;BwRCleiCYhAR30J9T78nnQ=="
---

